You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

s1

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)

Recruiting
  • Gastric Cancer
  • Jinan, Shandong, China
    Qilu hospital of Shandong univertisy
Mar 30, 2022

Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With

Enrolling by invitation
  • Gastric Cancer
  • Gastrectomy
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 1, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • S1
  • +3 more
  • Hangzhou, Zhejiang, China
  • +4 more
May 23, 2023

Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,

Recruiting
  • Phase II, Open-label, Parallel 2-arm, Multi-center
  • Gemcitabine 1000 mg
  • +4 more
  • Kaohsiung, Taiwan
  • +2 more
Jun 12, 2022

HER2-positive Gastric Cancer Trial in Jinan, Qingdao, Yantai (Disitamab vedotin, Tislelizumab, S1)

Not yet recruiting
  • HER2-positive Gastric Cancer
  • Disitamab vedotin
  • +2 more
  • Jinan, Shandong, China
  • +6 more
Oct 16, 2022

Gastric Cancer Trial in Tianjin (Comparing Hyperthermic Intraperitoneal Chemotherapy, Paclitaxel, S1)

Recruiting
  • Gastric Cancer
  • Comparing Hyperthermic Intraperitoneal Chemotherapy
  • +2 more
  • Tianjin, Tianjin, China
    Department of Gastrointestinal Medical Oncology, Tianjin Medical
Jan 26, 2022

Metastatic Pancreatic Cancer Trial in Shanghai (Donafenib, S1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Shanghai, China
    Fudan University
Nov 17, 2021

Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer Trial (Oxaliplatin,

Not yet recruiting
  • Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
  • (no location specified)
Jan 31, 2023

For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment

Not yet recruiting
  • For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
  • Shenyang, Liaoning, China
    Liaoning Tumor Hospital & Institute
Mar 7, 2023

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Wuhan (Camrelizumab, Apatinib

Recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Wuhan, Hubei, China
    Zhongnan Hopital of Wuhan University
May 14, 2021

Metastatic or Recurrent Gastric Adenocarcinoma Trial in Nanjing (Envafolimab, Oxaliplatin, S1)

Recruiting
  • Metastatic or Recurrent Gastric Adenocarcinoma
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Institute & Hospital
Apr 19, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Jul 25, 2023

Stomach Cancer Trial (Tirelizumab, Trastuzumab, Docetaxel)

Not yet recruiting
  • Stomach Cancer
  • (no location specified)
Aug 19, 2021

Gastric Cancer Stage Trial in Tianjin (sintilimab, apatinib, S1)

Recruiting
  • Gastric Cancer Stage
  • Tianjin, Tianjin, China
    Department of Gastrointestinal Medical Oncology, Tianjin Medical
Jul 5, 2021

Carcinoma, Pancreatic Ductal Trial in Shanghai (S1, Oxaliplatin, Irinotecan)

Recruiting
  • Carcinoma, Pancreatic Ductal
  • S1
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Apr 7, 2021

Advanced Gastric Cancer Trial in Fuzhou (Camrelizumab, Apatinib Mesylate, nab-paclitaxel)

Recruiting
  • Advanced Gastric Cancer
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Jun 3, 2020

Gastric Cancer Trial in Beijing (Camrelizumab, Oxaliplatin, S1)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Chinese PLA General Hospital
Apr 26, 2020

Superior Sulcus Tumor, NSCLC Stage IIB, Non Small Cell Lung Cancer Stage III Trial (drug, radiation, procedure)

Not yet recruiting
  • Superior Sulcus Tumor
  • +2 more
  • (no location specified)
Jul 7, 2020

Gastric Cancer, Locally Advanced Solid Tumor Trial in Guangzhou (JS001, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Locally Advanced Solid Tumor
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 5, 2020

Pancreatic Cancer Trial in Beijing (biological, drug, other)

Completed
  • Pancreatic Cancer
  • DC-CIK Treatment
  • +2 more
  • Beijing, Beijing, China
    Capital Medical University Cancer Center
Jan 16, 2018

Gastric Cancer, Chemoradiation Trial in Beijing (Hypo-fractionated radiotherapy, S1)

Unknown status
  • Gastric Cancer
  • Chemoradiation
  • Hypo-fractionated radiotherapy
  • S1
  • Beijing, Beijing, China
    Cancer Hospital, Chinese academy of medical sciences
Feb 8, 2018